Ignite Creation Date:
2025-12-26 @ 5:19 PM
Ignite Modification Date:
2025-12-26 @ 5:19 PM
Study NCT ID:
NCT06018506
Status:
TERMINATED
Last Update Posted:
2025-11-21
First Post:
2023-08-11
Is NOT Gene Therapy:
False
Has Adverse Events:
False
Brief Title:
A Phase I Study of BR108 in Hematological Malignancies
Sponsor:
BioRay Pharmaceutical Co., Ltd.
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2023-03-18
Start Date Type:
ACTUAL
Primary Completion Date:
2024-05-27
Primary Completion Date Type:
ACTUAL
Completion Date:
2024-06-21
Completion Date Type:
ACTUAL
First Submit Date:
2023-08-11
First Submit QC Date:
None
Study First Post Date:
2023-08-30
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-11-18
Last Update Post Date:
2025-11-21
Last Update Post Date Type:
ESTIMATED